Ventrus Biosciences Inc.
) was a big mover last session with shares rising nearly 11% on the
day. The move came on solid volume too with far more shares
changing hands than in a normal session. This continues the recent
uptrend for the company, as the stock is now up over 27% in the
past one-month time frame.
This specialty pharmaceutical company has seen no estimate revision
in the last 30 days. The Zacks Consensus Estimate hasn't remained
in trend either. Yesterday's price action is encouraging though, so
make sure to keep a close watch on this firm in the near future.
Ventrus Biosciences currently has a Zacks Rank #3 (Hold) while its
Some better-ranked stocks in the Med-Drug industry include
Lannett Company, Inc.
WuXi PharmaTech (Cayman) Inc.
Questcor Pharmaceuticals, Inc.
). While Lannett Company sports a Zacks Rank #1 (Strong Buy), WuXi
and Questcor carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
LANNETT INC (LCI): Free Stock Analysis Report
QUESTCOR PHARMA (QCOR): Free Stock Analysis
VENTRUS BIOSCI (VTUS): Free Stock Analysis
WUXI PHARMATECH (WX): Free Stock Analysis
To read this article on Zacks.com click here.